Toll-like receptor 2 is increased in neurons in Parkinson’s disease brain and may contribute to alpha-synuclein pathology

Nicolas Dzamko, Amanda M. Gysbers, Gayathri Perera, +5

Acta Neuropathologica

The olfactory receptor gene superfamily: data mining, classification, and nomenclature

Gustavo Glusman, Anita Y. Bahar, Dror Sharon, +3

Mammalian Genome

BiologyBioinformaticsNeurobiological MechanismFunctional GenomicsGenetics +7

Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subclone

Seoyeon Choi, Michelle J. Henderson, Edward Kwan, +11

Blood

Sequence, Structure, and Evolution of a Complete Human Olfactory Receptor Gene Cluster

Gustavo Glusman, Alona Sosinsky, Edna Ben‐Asher, +9

Genomics

BiologyNeurobiological MechanismFunctional GenomicsGeneticsComputational Biology +6

Molecular Ontogeny of Donor-Derived Follicular Lymphomas Occurring after Hematopoietic Cell Transplantation

Oliver Weigert, Nadja Kopp, Andrew A. Lane, +16

Cancer Discovery

Clinical significance of minimal residual disease at day 15 and at the end of therapy in childhood acute lymphoblastic leukaemia

Rosemary Sutton, Nicola C. Venn, Jonathan Tolisano, +9

British Journal of Haematology

The frequency of founder mutations in theBRCA1,BRCA2, andAPC genes in australian Ashkenazi Jews

Anita Y. Bahar, Peter J. Taylor, Lesley Andrews, +5

Cancer

Intracellular and secreted forms of clusterin are elevated early in Alzheimer's disease and associate with both Aβ and tau pathology

Claire E. Shepherd, Andrew J. Affleck, Anita Y. Bahar, +2

Neurobiology of Aging

Neurodegenerative DiseasesAlzheimer's DiseaseTau PathologyDegenerative PathologyProtein Misfolding +4

Prevalence of chronic traumatic encephalopathy in the Sydney Brain Bank

Heather McCann, Anita Y. Bahar, Karim Burkhardt, +4

Brain Communications

Improving the Identification of High Risk Precursor B Acute Lymphoblastic Leukemia Patients with Earlier Quantification of Minimal Residual Disease

Mawar Karsa, Luciano Dalla Pozza, Nicola C. Venn, +10

PLoS ONE